Rapid Structure-Function MRI of the Lung for Post-COVID-19 Management
The objective of this application is to develop novel rapid free-breathing four-dimensional (4D=3D+time) lung MRI techniques that will enable non-invasive radiation-free evaluation of lung anatomy and pulmonary function in the longitudinal follow-ups of post-COVID-19 patients. This novel imaging framework could provide a unique opportunity to augment post-COVID care, particularly for identifying COVID-19-induced lung abnormality in a timely manner and for studying the longitudinal changes of lung anatomy and global/regional pulmonary function.
RASolute 302: A Phase 3 Multicenter Open-label Randomized Study of RMC-6236 versus Investigator s Choice of Standard of Care Therapy in Patients with Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
This study is being done to find out if the treatment RMC-6236 can help patients with advanced pancreatic cancer live longer or keep their cancer from growing compared to standard chemotherapy chosen by the doctor. Patients in the study will be randomly placed into two groups: one group will get RMC-6236, and the other group will get one of four common chemotherapy treatments. Doctors will decide which chemotherapy treatment is best for each patient before the study starts. Patients will be grouped based on their activity level, whether their cancer spread right away, if they have liver tumors, and the type of RAS gene mutation in their cancer. The study has three parts: Screening (to check if a patient qualifies), Treatment (which continues until the patient stops for medical or other reasons), and Follow-up (to track health and survival after treatment ends). Scans to check tumor growth will be done every 8 weeks. The main goal is to see if RMC-6236 helps patients live longer or delays cancer growth compared to chemotherapy.
Reach Out Stay Strong Essentials for mothers of newborns (ROSE) Adaptation for Chinese American mothers
We are conducting a cultural adaptation and pilot study of a postpartum depression prevention intervention among pregnant Chinese American women. Once we establish feasibility and acceptability of the adapted intervention, we will conduct a pilot study. The study consists of focus groups, key-informant interviews, pre-intervention and post-inervetnion questionnaires, a debrief session, and a 7 session intervention.
Real Estate, Development & Facilities Design Guidelines | NYU Langone Health
NYU Langone has design guidelines for project managers, architects, and engineering teams.
Real Estate, Development & Facilities Procurement Opportunities | NYU Langone Health
NYU Langone offers procurement opportunities for various types of projects.
Reanimation Surgery for Facial Nerve Paralysis | NYU Langone Health
Surgeons at NYU Langone perform reanimation procedures to restore facial symmetry and reanimate facial muscles.
REBYOTA for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
This is a prospective observational cohort study designed to collect data on patients who received REBYOTA for the prevention of rCDI in the routine care setting. As all data collected for this study are observational, the decision to prescribe REBYOTA is at the treating physician’s discretion and independent from the decision to enroll the patient in the study. Adult patients who receive a prescription for REBYOTA to prevent rCDI are eligible to enroll according to the inclusion and exclusion criteria described below. Patients must enroll in the study between prescription and administration. This allows time for patients to enroll while still conducting the baseline measurement of patient-reported outcomes (CDI-DaySyms™) prior to administration. REBYOTAFor each patient, the current or presenting rCDI episode will be defined as the CDI episode just prior to receiving REBYOTA. If a patient receives REBYOTA more than once, the first dose will be used to define the presenting rCDI and to assess REBYOTA effectiveness.Baseline period will be defined as the time period between the date REBYOTA is prescribed and the date REBYOTA is administered.Data will be collected from patients’ medical records after obtaining informed consent. Data about clinical history, CDI events (primary and recurrent: severity, treatment), CDI-related symptoms, treatments, medical procedures, AEs, and healthcare resource utilization (i.e., hospitalizations and re-admissions) will be collected through 6 months of follow-up from the date of REBYOTA administration.
Reconstruction for Head & Neck Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center can reconstruct bone and soft tissues after surgery for head and neck cancer.
Reconstruction for Laryngeal Cancer | NYU Langone Health
NYU Langone doctors reconstruct the larynx and repair paralyzed vocal cords in people who have had surgery for laryngeal cancer.
Reconstruction Surgery for Distal Biceps Tendon Rupture | NYU Langone Health
NYU Langone orthopedic surgeons are experts at performing the latest reconstruction procedures for a distal biceps tendon rupture.